Filling the need for trusted information on national health issues…

Drug Resistance

  • Your Selections:

Refine Results

date

Tags

New York Times Examines Emergence Of XDR-TB In Australia, PNG

“Australia’s first death from XDR-TB — extensively drug-resistant tuberculosis, which is nearly incurable — has alarmed health officials and added new heat to a debate over how to treat immigrants with dangerous diseases,” the New York Times reports. “A long string of small Australian islands — bits of what was…

India, China Deny Claims Of Supplying Counterfeit Medications To Africa, Guardian Reports

“India has denied claims that it has exported large quantities of counterfeit medication to Africa, after the Guardian published a front-page exposé on the phenomenon,” the Guardian reports in a follow-up article. The original article “cited experts and NGO reports as saying that up to a third of anti-malarial drugs in Uganda and Tanzania might be fake or substandard, and the majority of them were manufactured in China and India,” the newspaper writes, adding, “The fake medications have led to deaths, prolonged illness and increased drug resistance in parts of east Africa, the article said.” According to the Guardian, “The Indian health ministry launched a huge campaign last month to check the quality of medication manufactured across the country.” In addition, “Chinese officials also denied the charges made in the report,” the newspaper notes, citing another article published on December 28 (Burke, 1/2).

More Action Needed To Fight TB, As Drug Resistance Spreading

“As we mark World [Tuberculosis (TB)] Day on Sunday March 24, there can be no denying that TB, fueled by drug resistance, continues to pose a serious global health threat — one that must be urgently addressed,” John Lechleiter, chair, president and CEO of Eli Lilly and Company and chair…

More Work Ahead In TB Drug Development, Treatment Delivery

The U.S. Food and Drug Administration’s approval of the tuberculosis (TB) drug Sirturo, also known as bedaquiline, “appears to be just the first step in an exciting renaissance for TB drug development,” Mark Harrington, executive director of Treatment Action Group (TAG), writes in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog. “Another new drug, delamanid, is currently in late clinical trials and has been submitted to the European Medicines Agency for review as a treatment for [multidrug-resistant (MDR)] TB,” he notes. Harrington concludes, “It’s an exciting time for TB treatment, but much more needs to be done and more resources are needed. We need to focus not only on the discovery and development of new drugs, but also on ensuring that news drugs are delivered to those who need them and in combinations that can prevent the emergence of new types of drug resistance” (12/28).

Fake, Poor-Quality Drugs Boosting Malaria Drug Resistance In Southeast Asia, U.S. Experts Say

“Fake or poor quality malaria drugs are boosting resistance in parts of southeast Asia, a problem that is likely to worsen unless tighter regulations are adopted, U.S. experts said Monday” at a hearing of the House Foreign Affairs Subcommittee on Africa, Global Health, and Human Rights, Agence France-Presse reports. “‘Drug resistance to the most effective drug available, artemisinin-based combination therapy, is developing and has been recognized in southeast Asia,'” Regina Rabinovich, director of infectious diseases at the Bill & Melinda Gates Foundation, said, according to the news service.

Annual European CDC Report Says Infectious Diseases, Drug Resistance Are Concerns

“Europe’s health is suffering, with around 80,000 cases of tuberculosis infection a year and serious problems with measles, HIV and threats from ‘superbug’ infections, an annual health report” from the European Centre for Disease Prevention and Control (ECDC) said Thursday, Reuters reports. The report said infectious diseases and antibiotic resistance, especially multi-drug resistance, are major concerns, according to the news service. The “report also identified several emergent diseases in Europe it said might pose a risk to public health,” including West Nile virus, malaria, dengue fever and chikungunya, Reuters notes.

Multi-Drug Resistant Bacteria Widespread In Europe, Report Says

Multi-drug resistant bacteria “are increasing their grip in Europe with rates of drug resistance in one type of bacteria reaching 50 percent in the worst-hit countries, health officials said Thursday,” Reuters reports. “In a report [.pdf] on multi-drug resistant bacteria, … the European Center for Disease Prevention and Control (ECDC), which monitors disease across the European Union, said the need to combat resistance was ‘critical,'” the news agency writes, adding, “To a large extent, antibiotic resistance is driven by the misuse and overuse of antibiotics, which encourages bacteria to develop new ways of overcoming them” (Kelland, 11/17).

Malaria Mortality Rates Down, But Progress Threatened By Funding Shortfall, WHO Report Says

“Malaria mortality rates have fallen by more than 25 percent globally since 2000, and by 33 percent in the WHO African Region, according to the World Malaria Report 2011, issued [Tuesday] by [the] WHO,” the organization reports in a press release. “This is the result of a significant scaling-up of malaria prevention and control measures in the last decade,” the press release adds. However, the press release notes, “WHO warns that a projected shortfall in funding threatens the fragile gains and that the double challenge of emerging drug and insecticide resistance needs to be proactively addressed” (12/13).

Blog Examines Funding For MDR-TB Versus Drug-Susceptible TB

In the Center for Global Development’s (CGD) “Global Health Policy” blog, Amanda Glassman, director of global health policy at CGD, and Kate McQueston, program coordinator at the center, examine spending on tuberculosis (TB), including drugs to fight susceptible and multidrug-resistant (MDR) strains of the bacteria. “[D]espite higher costs and relatively…

Also In Global Health News: Flooding, HIV Treatment Adherence, and Economic Growth In Africa; China Detects Superbug; U.S. Aid To Myanmar; Cash-Transfer Programs

1.8M Now Affected By Flooding In West And Central Africa; Hardest Hit-Benin Struggles With Disease, Damaged Health Centers Flooding continues to devastate Central and West Africa – more than 1.8 million people have been affected and 400 killed, according to the U.N., United Press International reports. “The nation of Benin has…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.